GCMG
BIIB icon

Gyroscope Capital Management Group’s Biogen BIIB Stock Holding History

Gyroscope Capital Management Group’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-1,571
Closed -$426K – 112
2017
Q2 		$426K Hold
1,571
– – 0.21% 63
2017
Q1 		$430K Hold
1,571
– – 0.26% 53
2016
Q4 		$446K Buy
+1,571
New +$466K 0.3% 45
2015
Q3 		– Sell
-2,500
Closed -$1.01M – 64
2015
Q2 		$1.01M Buy
+2,500
New +$1M 0.83% 34

Other funds holding BIIB

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Gyroscope Capital Management Group's BIIB Position: Q3 2017 in Review

Gyroscope Capital Management Group sold out of Biogen (BIIB) in Q3 2017, closing a stake of 1,571 shares — an estimated $426K sold.

Gyroscope Capital Management Group first reported a position in BIIB in Q2 2015 and held it in 4 quarters. The position peaked at $1.01M in Q2 2015. 1,014 funds tracked by Wall St. Rank hold BIIB as of Q3 2017.

  • Gyroscope Capital Management Group reported no remaining Biogen position as of Q3 2017 after selling out during the quarter.
  • Gyroscope Capital Management Group sold 1,571 Biogen shares in Q3 2017, an estimated $426K.
  • Gyroscope Capital Management Group first reported a position in Biogen in Q2 2015 and held it in 4 quarters.
  • Gyroscope Capital Management Group's Biogen position peaked at $1.01M in Q2 2015.
  • 1,014 funds tracked by Wall St. Rank held Biogen as of Q3 2017.

Based on Gyroscope Capital Management Group's 13F filing for Q3 2017, filed 16 Nov 2017.